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Almost all proteins found in biological systems are composed of L-configured amino 
acids. This general finding in nature is essential for the proper folding of proteins; a.-helices can 
only form if all of a protein's constituent amino acids adopt the same stereochemical 
configuration. 1 From this observation it would appear that amino acids of the D-configuration 
have no functional purpose in an organism. Despite this, D-amino acids have in fact been found 
in living organisms. Neurotoxins produced by Conus gladiator & Conus mustelinus (cone snails) 
have been found to contain D-valine. 2 In bacteria, D-alanine & D-glutamine have been found in 
peptidoglycan (a structural component of cell walls), and in mammalian brains, free D-serine has 
been recently identified as a neurotransmitter.3' 4 From these examples, it is appears as though D-
amino acids are more common in biological systems than one would suspect at first glance. 
Interestingly, recent evidence has emerged which implicates the presence of these D- amino 
acids ·with Alzheimer' s disease. 
In a 1998 study by Fisher eta/, samples of cerebrospinal fluid (CSF) from Alzheimer 
patients and normal subjects were assayed for total free D-amino acid content. 5 These 
researchers importantly discovered significantly higher levels of free D-amino acids in CSF from 
Alzheimer patients, compared to normal subjects. However, their study was not complete 
because it did not investigate free threonine in all of its stereoisomeric forms (only D-threonine 
content was analyzed). This may be partly due to the fact that studying free threonines requires 
the ability to separate enantiomers and diastereomers (all in the same mixture). A separation of 
this type is usually quite technically challenging and often requires the use of specialized and 
expensive equipment (in the form of chiral chromatography columns). Due to the technical 
hurdle and time-consuming nature of these separations, the threonine case was understandably 
left uninvestigated. However, recent work by Serafin et al has shown that tandem mass 
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spectrometry can simplifY the process of stereospecific identification of amino acids~ especially 
in the case of free threonine.6 As mentioned previously, threonine poses a novel challenge for 
analysis because unlike the other 18 stereogenic amino acids, threonine has four possible 
stereoisomers (see Figure 1). 
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Figure 1: The four stereoisomers of threonine. 
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Serafin et a! demonstrated that among these four stereoisomers (Figure 1 ). threonine 
diastereomers are more likely form a different charged species VEthen ionized and fragmented via 
collision-induced dissociation (CID). 6 The different charged species from each diastereomer can 
be seen in the mass spectra and the relative abundance ratio of two key ions can be directly 
correlated to the abundance of each diastereomer in the original sample. 6 However, one caveat of 
such a method is a requirement for each sample to contain only threonine diastereomers; 
enantiomers cannot be quantified via this method because each enantiomeric pair will fragment 
in exactly the same way. However, given the ever growing and widespread use of mass 
spectrometry, such a detection method is certainly desirable because it will widen the 
applicability of our method. Thus, if tandem mass spectrometry (MS/MS) is going to be used for 
our analysis, a san1ple can only contain mixtures of L- & L-allo threonine or mixtures of D- & 
D-allo threonine. 
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The above requirement presents an obvious problem if a sample contains a mixture of all 
four threonine stereoisomers, which c.ould potentially be the case if the sample is an extract from 
a biological source. We have been unable to find any previous biological analysis of all four 
threonine stereoisomers and must therefore assume all are present. In order for D-threonines in 
this mixture to be quantified via MS/MS, the L- & L-allo enantiomers need to be removed. 
Research conducted by Liu et al has presented us with a novel solution to this separation 
problem, which does not involve the use of chiral chromatography columns. In their study of E. 
coli bacteria, a low-specificity L-threonine aldolase (L T A) was identified, which specifically 
catalyzes the conversion of L- & L-allo threonine into glycine and acetaldehyde; D- & D-allo 
threonine were not compatible substrates. 7 Thus, L T A can potentially be used to help solve the 
problem faced if a sample contains all four threonine stereo isomers; adding L T A will rid the 
sample of any L-threonines and leave behind only the D-threonines (see Figure 2). 
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Figure 2: Reaction scheme of proposed method for L TA-assisted threonine separation. A biological sample may 
contain any or all forms of threonine (left side of reaction arrow). By mixing the sample with LTA, the L- threonines 
are effectively eliminated from the sample, which leaves only the D- threonines. 
As stated before, these D-threonines can then be quantified via MS/MS. Unfortunately, LTA is 
no longer commercially available and as far as we can tell, no other lab in the cow1try is actively 
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working with it. Therefore in order to obtain LT A, we have to make it ourselves, which has been 
a large focus of our research. 
In principle, L T A could be obtained from wild-type E. coli by growing the bacteria in 
multi-liter cultures and using traditional ~~grind and find" biochemical methods to extract and 
purify the enzyme. While such a process is feasible, it is also time consuming because multiple 
purification steps are involved. For this reason, we took a different approach to obtain LT ~ 
which takes advantage of the E. coli genome having been completely sequenced and published. 
This means the L T A gene can be precisely cloned, inserted into an expression plasmid, and used 
to transform a host organism (BL21 (DE3) E. coli). The transformed bacteria can then be grown 
in large-scale culture, from which LT A can be extracted. In our venture to obtain LTA we 
decided to use a pET expression vector system, which has several important features that allow 
us to conduct a more precise LT A purification compared to "grind and find." See Figure 3 for 
details about our complete expression vector system. 
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Figure 3: Complete pET plasmid used for purification ofL TA (created summer of2008 by Brian Monk). 11 The 
gene encoding for L-threonine aldolase is shown in red. The plasmid also contains a his-tag, which simplifies 
purification (blue). A lac operon (green) has been inserted to control production of the enzyme. The bacteriophage 
TI RNA polymerase promoter (purple) allows for selective expression of the gene because the T7 promoter is not 
used elsewhere by the host organism because it is a viral promoter and thus creates a dedicated expression system. 
Selection of our bacteria containing tbis plasmid is aided by the ampicillin-resistance (Amp') gene (orange) because 
non-transformed cells will be .ki11ed when ampicjJlin is added to the media. The Ori (ye11ow) ensures the Plasmid 
DNA wilJ be replicated in vivo as the bacteria go through their reproduction cycle. 
The first important feature is a lac control system upstream of our cloned gene. When 
bound to its opero14 the lac repressor protein prevents transcription of the L T A gene. The 
repressor can be removed by addition of galactose or a lipid-soluble homolog, isopropyl-thiol-D-
galactoside (IPTG). Such a system allows us to precisely control when the LT A gene is 
expressed and also gives us the option of over-expressing the L T A gene. By over-expressing the 
L T A gene, we can theoretically obtain more L T A enzyme per bacteria cell, compared to normal 
expression levels. A second important plasmid feature is the T7 viral promoter site. Because 
BL21 (DE3) E. coli have been genetically engineered to produce the bacteriophage T7 RNA 
6 
polymerase, expressing the L T A gene can be carried out with a dedicated polymerase. In 
addition, the plasmid also adds six histidine residues to the N-terminus end of L T A (also known 
as a his-tag). Importantly, these six histidine residues allow nickel affinity chromatography to be 
used as our primary protein purification method. Because of histidine's extremely high affinity 
for Ni2+, the crude cellular extract from our transformed host can be decanted into a 
chromatography column containing immobilized nickel ions. His-tagged LTA will associate very 
strongly with the nickel ions while all of the other cellular proteins and cell debris flow through 
the column. As a result, LTA can theoretically be purified in extremely high yield after only one 
purification step. 
Once LT A is purified, we will need to perfonn a kinetics assay and verify that LT A can 
be used to rid a biological sample of all L-threonines. The reported Km for L T A is in the 2-4 mM 
range 7, but the concentration of threonine in our proof of concept sample (blood plasma) is in the 
0.1-0.2 mM. range. 8 We will need to optimize incubation conditions for L T A in order to ensure 
sufficient catalytic activity is being achieved at these low substrate concentrations. 
Because the presence of freeD- threonine has already been established in human CSF,5 
there is precedent for developing a method which can detect D-allo threonine as well. It is the 
ultimate goal of our research to develop such an analysis method. However, in creating our 
method, we are striving to ensure that it can be carried out without the use of chiral 
chromatography columns and thus be easily applied in a clinical laboratory setting. If 
demonstrated to be reproducible and accurate, our analysis method has the potential to greatly 
simplify the task of measuring free D- threonines in a biological matrix because we will be able 
to assay both D-forms in the same experiment. Once their existence (or lack thereof) has been 
established in a laboratory animal, we would like to take samples (in the form of CSF) from 
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individuals afflicted with degenerative disorders and detennine the relative amounts of this free 
D· amino acid. These data would allow us to determine if there is a correlation between the 
presence of free D- threonines and a given degenerative disorder. 
Experimental 
Transformation of Host Cells 
The following transformation procedure was adapted from a Novagen® cloning kit user 
protocol.9 
Day 1: BL21 (DE 3) E. coli were used as the expression strain for production ofLTA. To 
begin the transformation, a tube ofNovaBlue Singles Competent Cells was removed from the 
freezer and allowed to thaw on ice and resuspended. One J.1L of the pET expression plasmid 11 
(created by Brian Monk) was then added to the competent cells. The mixture was then allowed to 
incubate on ice for 5 minutes. Following the ice incubation, the cells were transferred to a 42 °C 
water bath for exactly 30 seconds. The transformed cells were then placed on ice for 2 minutes. 
Next, 250 J.1L of SOC media was added to the cells. Twenty J.1L of the mixture was then spread 
on LB agar media. Antibiotic was added by top.spreading 200 J.1L of 50 mg/mL ampicillin. The 
plate was then incubated overnight at 37 °C. 
Day 2: Each distinguishable colony was transferred to liquid culture (3 7 oc with 250 
RPM shaking) by re-suspension in 5 mL ofLB media containing 0.5 mglmL ampicillin. Liquid 
cultures were maintained until colonies with the L TA gene insert were identified. 
Plasmid Insert Verification 
After 16 hours in liquid culture, a 1 mL aliquot was removed from each culture tube. 
Then, using a Qiagen ®DNA Mini extraction .kit, representative DNA was extracted from each of 
the former colonies. When DNA extraction was completed, 1 J.1L of the extract was transferred to 
a PCR reaction tube with the following L T A gene specific primers: 
5'GACGACGACAAGATG3' (forward} and 5'GAGGAGAAGCCCGGTAA3' (reverse). 
Primers were added to a final concentration of 0.5 J.tM. The thermo cycler was run according to 
the following protocol: 94.0 oc for 5 min, 55.5 oc for 45 seconds and 72.0 oc for 2 minutes. The 
cycle was then repeated for a total of 30 cycles. Amplification products were then transferred to 
an 0.8% agarose gel. ran at 120 volts, and stained with ethidium bromide. The presence of 
amplification products (seen via UV illumination of the gel) was used to identify recombinant 
cells containing the L TA gene insert. 
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Storage of Recombinant Cells 
Once L T A gene-containing cultures were identified, aliquots were removed and mixed 
with glycerol to a final concentration of 10 % by volmne. The cells were then flash frozen with 
liquid nitrogen and stored at -70 oc for future use. 
Threonine Aldolase Gene Expression Verification & IPTG Expression Gradient 
A container of frozen L T A expression strain was thawed and distributed among 8 test 
tubes containing 5 mL LB media and 0.5 mg/mL ampicillin. Half of these culture tubes were 
placed in a 30 oc water bath and the other half were placed in a 32 oc water bath. Each was set 
to 250 rpm. Cell growth was then followed spectrophotometrically by monitoring absorbance at 
550 run. When an absorbance of0.5 was reached, the following IPTG concentration gradient was 
setup in separate tubes: 0 m.M, 0.1 mM, 0.2 mM and 0.5 mM. However, before addition ofiPTG, 
a I rnL aliquot was removed from each culture and spun down to collect cells. After 21 hours, an 
identical aliquot was removed and spun down to collect the cells. Each pellet was then re-
suspended in 200 ~L LSB. Ten ~L of each re-suspension was then loaded onto an 12.5% 
polyacrylamide gel and run at 120 volts for 1 hour. The separated proteins were then stained with 
Coomassie blue. 
Large Scale Purification of Threonine Aldolase by Nickel Affinity Chromatography 
Day 1: A tube of frozen cells was removed from the ~ 70 °C freezer and immediately 
thawed in a 3 7 oc water bath. 60 J.tL of the cell mixture was then transferred to 5 mL of LB 
media containing 0.5 mg/mL of ampicillin. The culture was then incubated at 37 oc in a shaking 
water bath (250 rpm) overnight. 
Day 2: 1.5 mL of the overnight culture was transferred to a flask containing 250 mL of 
LB media and ampicillin (0.5 mglmL). The new culture was then placed into a shaking water 
bath set at 32 °C and 250 rpm. The culture growth was then monitored spectrophotometrically by 
monitoring the absorbance of the culture mixture at 550 run. When an absorbance reading 
between 0.5 and 1.0 was obtained (usually between 6-9 hours), IPTG was added to the culture to 
a final concentration of0.15 mM. The cell culture was then allowed to grow for 18-20 hours. 
Day 3 (Part 1): Cells were collected from the culture by centrifugation at 10,000 g for I 0 
minutes. During centrifugation and from this point on, all cellular extracts were kept between 0 
and 4 °C at all times. After decanting the supernatant, the pellet was re-suspended with 25 mL of 
a pH 7.9 solution containing 0.25 M NaCI, 20 mM Tris-HCl, and 5 mM imidazole. Once re-
suspended, the collected cells were placed on an ice bath and sonicated with a Branson Sonifer 
450. The instrwnent was set at power level 4 and a duty cycle of 10. The extract was sonicated 
for a total of 8 minutes, but carried out in 2 minute bursts, followed by 1 minute rest intervals to 
avoid overheating the extract. During each rest interval, a small aliquot of the suspension was 
examined via clarkfield microscopy at 1 OOOx magnifica~ion, in order to monitor the lysing of 
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cel1s. After completing the sonication procedure, the suspension was spun at 20,000 g to remove 
any insoluble material. The post-centrifuga1ion supernatant was then filtered through a 0.45 }lm 
syringe-end filter. Absorbance readings were taken at 260 & 280 nm using a Spectral Solutions 
Inc CCD Array UV-Vis spectrophotometer to determine the approximate protein concentration 
of this crude extract. 
Day 3 (Part ll): The affinity chromatography column was prepared by allowing 2 mL of 
His-Bind® resin to settle in a 2.5 mL polypropylene chromatography column. The column was 
then washed with 6 mL of sterile deionized water. Next, l 0 mL of 50 mM NiS04 was passed 
through the column, followed by 6 mL of a pH 7.9 solution containing 0.25 M NaCl, 20 roM 
Tris-HCl, and 5 mM imidazole. 
Day 3 (Part III): The crude extract was then loaded onto the column and washed with a 
pH 7.9 solution containing 0.25 M NaCl, 60 mM imidazole and 20 mM Tris-HCl. Another wash 
was conducted by loading 20 mL of a pH 7.9 solution containing 0.25 M NaCl, 20 rnM Tris-
HCI, and 5 mM imidazole onto the column. To begin elution ofLTA, 12 mL of a pH 7.9 solution 
containing 1 M imidazole, 0.25 M NaCl and 20 mM Tris-HCl was loaded onto the column. 
Collection of LTA began after letting the first 2 mL of eluent flow into the waste container. After 
the second 2 mL volume was collected, the rest of the flow-through was discarded. Collected 
eluent was then mixed with glycerol to a final concentration of 50 % glycerol by volume. The 
mixture was then flash frozen with liquid nitrogen and stored at -70 °C. 
Note: A small aliquot of the column eluent (-20 j.LL) was kept aside for analysis via SDS-
PAGE (8%) acrylamide. 
Dialysis/ Refolding of Purified Threonine Aldolase 
Five 0.5 mL aliquots of previously frozen LTA solution were each loaded into a separate 
segment of dialysis tubing and each placed into a separate NaCl solution. The NaCl 
concentrations used were 0 M, 0.1 M, 0.25 M, 0.50 M and 0.75 M. Each dialysis solution also 
contained 50 mM K2HP04 at and 0.1 mM DTT. In addition, the pH of each solution was 
· adjusted to 8.5. All solutions were kept between 0 and 4 °C and allowed to incubate for 3 hours. 
The enzyme aliquots were then transferred to identical buffer solutions and allowed to incubate 
for another 3 hours. However in the second buffer solution, DTT was replaced with 20 f.J.M 
pyridoxal5' phosphate. At the end ofthe second 3 hour incubation, each aliquot was mixed with 
glycerol to a final concentration of 50% by volume and flash frozen with liquid nitrogen. The 
frozen aliquots were stored at -70 °C for later analysis. 
Enzyme Kinetics Protocol 
To verify the activity of threonine aldolase, the following kinetics protocol was adapted 
from a study conducted by Liu et al. 7 First, 10 f.J.mol of pyridoxal5' phosphate and 20 f.J.mol of 
HEPES buffer (pH adjusted to 8.0) were added to an Ependorf tube. Second, L-threonine was 
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added to an anticipated final concentration between 2mM and 50 mM (depending on the 
experiment). If necessary, the volume was adjusted to 120 J.!L with water. Once all reagents were 
mixed, 80 J.!L of a solution containing L T A was added to the mixture to give a final volume of 
200 JlL. Due to the dynamic nature of protein purification. the exact amount of L T A added to 
each incubation tube varied between purifications. The enzyme catalyzed reaction was then 
carried out a 60 oc for 20-60 minutes (depending on the experiment). At the end of the allotted 
time interval, the reaction was quenched by adding 60 JlL of a 30% trichloroacetic acid solution. 
A blank for zeroing the spectrophotometer was prepared and treated identically to the other 
samples, except water was added in place of the L T A -containing solution. 
Note: Because glycerol was used as a preservative for L TA, it was present in all 
incubation mixtures at an approximate concentration of20% (v/v). Also, when samples were run 
with mouse plasma, 20 J.!L of the plasma were added in place of a prepared threonine solution 
(same final volume of200 J.LL). 
Determination of Acetaldehyde Produced by L T A Catalvsis 
The amount of acetaldehyde produced by the enzyme-catalyzed reaction was determined 
by adapting a protocol developed by Paz et al. 10 Two hundred J1L of the quenched catalysis 
reaction were mixed with 1000 J.LL ofO.l M glycine buffer (pH= 4) and 200 JlL ofO.l% (w/v) 
N-methyl benzothiazolone hydrazone (MBTH). The final volume was then adjusted to 2000 JlL 
with water. The prepared mixtures were then incubated ~t 40 °C for 30 minutes. The absorbance 
of each solution was then read at 306 nm using a Spectral Solutions Inc CCD Array UV-Vis 
spectrophotometer. Beer's law was then used to determine the amount of acetaldehyde added to 
the reaction (Ext: 22 L mmor1 mm·1). 
Determination of Protein Concentration in Purified Extracts 
Overall protein concentration was determined via Bradford assay. 50, 40, 30, 20, 10 and 
5 J.Lg BSA standards were prepared and made up to a final volume of 100 J.LL. The standards were 
then mixed with 5.0 mL of Bradford reagent and allowed to incubate for 5 minutes. The 
absorbance of each was then read at 595 nm using a Spectral Solutions Inc CCD Array UV-Vis 
spectrophotometer. The purified extract was then diluted into the standard range (if necessary) 
and read alongside the standards. 
Precautions Taken to Minimize Damage During Thawing 
In order to ensure optimum viability of frozen cells and L T A enzyme, all mixtures being 
removed from -70 °C storage were immediately buried in ice and then rapidly transported to a 37 
oc water bath for rapid thawing. Once thawed, all mixtures were placed back on ic-e until needed. 
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Results 
Identification/ Verification of Recombinant E. coli 
Competent BL21 DE3 E. coli were transformed with a pET expression plasmid 
containing the L T A gene insert via a heat shock technique. After plating the transformed cells on 
Ampicillin-containing media, 26 recombinant colonies were found after an overnight incubation. 
Once recombinant colonies were visible, each was transferred to liquid culture to allow 
for continued propagation. After growing overnight in liquid culture, DNA was extracted from 
each colony and run in a separate PCR reaction using L T A gene-specific primers. Amplification 
products from each of these reactions were then loaded onto an agarose gel and visualized 
(figure 4). 
Figure 4: Amplification products from PCR reaction with LTA gene-specific primers. Lane 1: DNA 1000 
BP ladder. Lane 2: Negative control from PCR reaction (water blank). Lane 3-20: Amplification products 
from PCR reaction with extracted DNA from colonies 1-18. Lane 21: DNA BP ladder. Lane 22-29: 
Amplification products from PCR reaction with extracted DNA from colonies 19-26. Red boxes denote 
the most significant amplification, detennined by ethidium bromide staining/ UV visualization. 
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Data from this experiment shows successful LTA gene amplification from the PCR with DNA 
extracts from colonies 2, 6 and 18. While other positive amplification results are definitely 
visible, the bands from colonies 2, 6 and 18 were the most prominent when visualized under an 
ultraviolet light source. 
To double check the previous positive amplification result, a representative sample from 
colony 6 (T AEXP 6) was removed from storage and grown to confluency in six separate culture 
tubes. After extracting DNA from each of these replicate cultures and running a L T A gene-
specific PCR reaction, the presence of the L TA gene insert was again visualized on an agarose 
gel (Figure 5). 
Figure 5: Amplification products from PCR reaction with L T A gene-specific primers. Lane l: 
DNA 1000 BP ladder. Lane 2: Negative control from PCR reaction. Lanes 3-8: DNA extracted from 
representative sample of colony 6. Note: A loading error was encountered when setting up PCR reaction 
for Jane 6. 
Data from this experiment again demonstrates that DNA from colony 6 produced successful 
L T A gene amplification. 
Threonine Aldolase Gene Expression Verification & IPTG/ Temperature Gradient 
After setting up 2 parallel cultures (one at 30 °C and one at 32 °C), varying concentrations 
of IPTG were added to different culture tubes in each temperature setting. Pre and post aliquots 
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were taken from each culture tube and analyzed for overall protein composition via SDS-PAGE. 
Data from the 30 OC experiment are shown in Figure 6 and data from the 32 OC experiment is 
shown in Figure 7. 
Figure 6: SDS-PAGE analysis of protein extracted from ceJJ cultures at 30 °C during IPTG concentration 
gradient test. T; aliquots were taken after approximately 8 hours of growth (before IPTG was added). Tr 
aliquots were taken after approximately 21 hours of growth. Lane 1: Broad range MW standard. Lane 2: 
No IPTG T1• Lane 3: No IPTG Tr. Lane 4: O.l mM Ti. Lane 5: O.l mM Tr. Lane 6: 0.2 mM Ti· Lane 7:0.2 
mM Tr. Lane 8: 0.5 mM T;. Lane 9: 0.5 mM Tr. Boxed region in red comsponds to a molecular weight of 
35 kD~ which is close to where threonine aldolase should appear (MW~34 kDa). 
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Figure 7: SDS-PAGE analysis of protein extracted from cell cultures at 32 OC during IPTG concentration 
gradient test. Ti aliquots were taken after approximately 8 hours of growth (before IPTG was added). Tr 
aliquots were taken after approximately 21 hours of growth. Lane 1: Broad range MW standard. Lane 2: 
No IPTG T;. Lane 3: No IPTG Tr. Lane 4:0.1 mM T;. Lane 5:0.1 mM Tr. Lane 6:0.2 mM T;. Lane 7:0.2 
mM Tr. Lane 8: 0.5 mM T;. Lane 9: 0.5 mM T f· Boxed region in red corresponds to a molecular weight of 
35 kDa, which is close to where threonine aldolase should appear (MW-34 kDa). 
Data from this experiment shows a distinct band around the 35 kDa region from all cultures 
exposed to IPTG at all concentrations. Thls demonstrates the cells are producing a protein with a 
molecular weight of~ 34 kDa following exposure to IPTG. However, protein bands from cultures 
with 0.1 mM IPTG (Fig. 6lane 5 & Fig. 7 lane 5) appear to be the most prominent. Due to the 
poor quality of the gel in Figure 6, it is difficult to determine which of these two bands (Fig. 6 
lane 3 & Fig. 7 lane 5) is most prominent. 
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Examination of Cell Suspensions during Sonication Process 
Samples of the cell re-suspension were analyzed during sonication to monitor lysing of 
ceBs. Data from these observations are shown in Figure 8. 
a b c 
Figure 8: Photos taken of cell re-suspension mixture at various intervals during sonication. Sa: Pre-
sonication. 5b: 3 min, 30 sec sonication. 5c: Completed 8 min sonication. All photos were taken using 
1 OOOx darkfield microscopy. 
i 
Analysis of photos presented in Figure 8 clearly reveals the majority of cells were suc~essfully 
lysed following an 8 minute sonication. 
Large Scale Purification of L T A 
Once collected, a small fraction of affinity chromatography eluent was analyzed via SDS-
PAGE. In addition, the post-dialysis solution was also analyzed for protein composition in the 
same gel. Data. from this experiment are shown in Figure 9. 
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Figure 9: SDS PAGE of affinity chromatography column eloents and dialyzed extracts. Lane l: Broad 
range MW standard. Lane 2: Column 1 eluent. Lane 3: Column 2 eluent. Lane 4: Column 2 eluent after 
dialysis. Boxed region in red corresponds to a molecular weight of 50 kDa. The large bands in this region 
correspond to the bulk of the purified protein. 
Data from Figure 9 clearly show an extremely prominent band around 50 kDa in all lanes, which 
indicates the presence of a purified protein. Importantly, lane 3 from Figure 9 also shows this 
protein is still present following dialysis. There is also another protein present in the 100 kDa 
region. though it is clearly not as abundant as the 50 kDa protein. 
Determination of Protein Concentration in Column Eluent and Dialyzed Extracts 
To determine the amount of purified protein, a Bradford assay was used to determine the 
protein concentration in the column eluent and in the post-dialysis solutions. BSA was chosen as 
the protein for making a standard curve (Figure 10). 
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Figure 10: Bradford assay standard curve. 5, 10, 20, 30, 40 and 50 ~g standards of BSA were prepared 
and read at 595 nm. 
The high correlation coefficient (0.99) in Figure 10 demonstrates an accurate standard curve was 
made for protein amounts between 5 Jig and 50 Jig. An aliquot from the column eluent and from 
each of the dialyzed extracts were taken, diluted if necessary, and mixed with Bradford reagent. 
The determined protein concentrations are shown in Table 1. 
Table 1: Overall protein concentration in each sample is shown below, as determined via the standard 
curve in figure 6. Listed NaCl concentrations refer to the specific dialysis treatment conducted. Note: All 
samples contained 50% (v/v) glycerol. 
Sample (M NaCI) Protein Concentration (pg/mL) 
0.0 11 0 
0.1 90 
0.25 80 
0.5 190 
0.75 130 
Column Eluent {undialyzed) 350 
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Determination LTA Specific Activity After Dialysis/Refolding Treatment 
Following dialysis, each extract was incubated under identical conditions to determine if 
the refolding process and/ or varying salt concentrations had any effect on overall enzyme 
activity. By comparing these treated extracts to the oodialyzed control, we could determine if 
these treatments were doing anything to optimize L T A activity. Results from these tests are 
summarized in Figure 11. 
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Figure 11 : Comparison of averge L T A specific activity values following different refolding treatments. 
Each enzyme sample was incubated for 60 minutes at 60 °C with a 2.0 mM substrate concentration (L-
threonine ). Production of acetaldehyde was determined spectrophotometrically using MBTH. All 
averages were found to be significantly different using ANOVA (p<O.Ol ). Note: the dialysis treatment 
was only performed once. The replicate measurements were taken from three enzyme mixtures subjected 
to the same dialysis treatment. 
Data presented in Figure 11 clearly demonstrates that refolding in combination with a 0.25 M 
NaCI concentration during dialysis results in a significantly higher activity (p<O.Ol ), compared 
to any other treatment. Importantly, the activity resulting from the 0.25 M treatment is even 
higher than the coloom eluent, despite the treated enzyme being subjected to an addition freeze/ 
thaw cycle. 
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Determination of Reaction Progress Over Time 
Because the goal of our project is to eliminate threonine enantiomers in a biological 
sample, we needed to follow the reaction over time to determine when all of the L- threonine 
isomers had been consumed. To carry out this study, three parallel enzyme incubations were 
setup with 5 mM L- threonine as the substrate. A reaction was quenched and assayed at an 
interval over the course of 165 minutes. Data from this experiment is shown in Figure 12. 
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Figure 12: Reaction progress ofLTA-catalyzed reaction over time with 5 mM L- threonine as the 
substrate. Absorbance readings taken according the method of Paz eta/. Absorption at 295 nm directly 
relates to the concentration of acetaldehyde via the Beer-Lambert Law. 
Results from this experiment show that reactions left incubating for a long period of time ( 120 
minutes and 165 minutes) contain less acetaldehyde in their respective incubation solutions, 
compared to the 60 minute reaction. 
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Demonstration of L T A Activity 'With Substrate from Biological Sample 
Mouse plasma was chosen as the biological sample to use as our "proof of concept" 
method trial. As such, mouse plasma was added to the incubation mixture instead of a prepared 
threonine solution. Data from this trial is shown in TabJe 2. 
Table 2: Absorbance data from LTA-catalyzed reaction (65 minute duration) with mouse plasma as the 
threonine source. Absorption at 295 nm directly relates to the concentration of acetaldehyde via the Beer-
Lambert Law. Note : the observed peak was partially obscured by noise at the neighboring wavelengths 
(probably from compounds in the blood). 
Sam le Name Abs at 295 nm 
---Incubation with Mouse Plasma 0.6 
~-------------------------
This experiment clearly shows production of acetaldehyde when mouse plasma was used as the 
threonine source. Unfortunately, the 295 nm peak could not be completely resolved due to noise. 
Discussion 
The presence of amplification products after running a PCR reaction with L T A gene-
specific primers and recombinant colony DNA clearly demonstrates that we created a strain of 
BL21 (DE3) E. coli \Vith the L T A gene insert. Because the gene is under control of the lac 
operon, we were able to induce expression of this gene by adding IPTG to the cell culture at an 
optimized concentration. Once grown to confluency, we were able to extract and purify LTA in 
extremely high purity and in a relatively high yield by using nickel-affrnity chromatography. 
Appropriate sonication conditions were experimentally determined to optimize the early stages 
of the purification, which ensured minimal damage to the enzyme. We also kept the enzyme 
between 0 and 4 °C at all times during the purification to further aid in this regard. Once purified, 
a small sample of the column eluent was assayed via SDS-PAGE, which revealed two distinct 
protein bands. We assumed the darker band corresponded to purified L T A and disregarded the 
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heavier protein seen on the top ofthe gel. To optimize LTA activity, we subjected the enzyme to 
a refolding treatment with a mild reducing agent and transferred the enzyme to a more stable 
phosphate buffer system at pH 8.5. 7 In the dialysis process, we decided to setup a concentration 
gradient with different concentrations of sodium chloride to detennine if a particular 
concentration could afford a higher enzyme activity. After carrying out kinetics assays of L TA at 
these varying salt concentrations, we found a 0.25 M sodium chloride concentration during 
dialysis produced optimal specific activity. This result was found to be statistically significant by 
AN OVA (p<O.Ol ). The enzyme catalyzed reaction was also carried out with mouse plasma as the 
threonine source to demonstrate its viability with a biological sample. 
Now that we know the conditions necessary to generate optimal activity of LT A, we can 
make our purification process more efficient by using chromatography buffers to match these 
conditions. This should expedite the overall purification process and allow us to move on to the 
next aspect of our project. 
Before we can use our proposed method we need to demonstrate that L T A can catalyze 
significant conversion of low concentration U L-alla threonine into glycine and acetaldehyde. If 
our analysis method is going to wo~ we need to be certain that all enantiomers are removed 
from a given sample. Following acetaldehyde production over time produced a surprising result 
in this regard because the data showed acetaldehyde concentration to be lower when the reaction 
was allowed to incubate for longer periods of time. Off hand, this means the reaction is actually 
going in reverse over time, as opposed to converting L- & L-allo threonine into acetaldehyde and 
glycine. However there is another explanation when you consider the properties of acetaldehyde. 
As it turns out, acetaldehyde is not a terribly stable compound and boils above 20 °C 
temperatures. Given the fact that our reaction temperature is 60 °C, it is possible that the 
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acetaldehyde is boiling and/or thermally decomposing. This would explain why its concentration 
decreased over time during the reaction. If this is the case, we will need to use LC/MS to monitor 
the reaction progress over time by measuring glycine production instead of acetaldehyde. By 
using mass spectrometry as a detection method, we will be able more accurately determine if and 
when the reaction is going to completion. Because such an instrument is not currently available 
in our laboratory, we could test the acetaldehyde decomposition hypothesis by making a solution 
of acetaldehyde that matches the expected concentration of a completed reaction and placing it at 
60 °C. This mixture could then be incubated and monitored over the course of three hours. 
Results from such an experiment would allow us to determine if there is actually enough 
acetaldehyde in solution to undergo significant decomposition and/or vaporization. 
References 
1: Nelson, David L & Cox, Michael M. "Lehninger Principles of Biochemistry." W.H. Freeman 
and Company; New York. 2008. pp 118-119. 
2: Pisarewicz, K., Mora, D., Pflueger F., Fields, G., Mari, F. {2005). "Polypeptide chains 
containing D~gamma-hydroxyvaline". Journal of the American Chemical Society 127 (17): 
6207-15. 
3: Wolosker, H.; Durnin, E., Balan L., Foltyn V. N. (July 2008). "D-amino acids in the brain: D-
serine in neurotransmission and neurodegeneration". FEBS Journa/215 {14): 3514-26. 
4: J., van Heijenoort (2001). "Formation of the glycan chains in the synthesis of bacterial 
peptidoglycan". Glycobiology 11 {3): 25R-36R. 
5: Fisher G., Lorenzo N., Abe H., Fujita E., Frey W.H., Emroy C., DiFiore M.M., Aniello A.D. 
"Free D- and L- amino acids in ventricular cerebrospinal fluid from Alzheimer and normal 
subjects." Amino Acids. VoL 15. April 16, 1998. 
6: Serafin S., Zhang K., Aurelio L,. Hughes A., Morton T. "Decomposition ofProtonated 
Threonine, Its Stereoisomers, and Its Homologues in the Gas Phase: Evidence for Internal 
Backside Displacement" Organic Letters. Vol6. 1561-1564. February 19,2004 
23 
7: Liu J., Dairi T., Jtoh N., Kataoka M., Shimizu., Yamada H. ''Gene Cloning, biochemical 
characterization and physiological role of a thermostable low-specificity L-threonine aldolase 
from Escherichia coli." European Journal of Biochemistry. 1998. Vol255. 220-226. February 
3, 1998. 
8: Stegink L., Flier L., Brummel M., Baker G., Krause W., Bell E., Ziegler E. "Plasma amino 
acid concentrations and amino acid ratios in normal adults and adults heterozygous for 
phenylketonuria ingesting a hamburger and milk shake meal." American Journal of Clinical 
Nutrition. Vol 53. 670-675. August 15, 1990. 
9: Novagen®. User Protocol TB 183 Rev. C 0404. Perfectly Blunt® Cloning Kits. EMD 
Biosciences Inc. 2004. 
10: Paz M.A., Blumenfeld 0. 0., Rojkind M., Henson E., Furfine C., Gallop, P.M. 
"Determination of Carbonyl Compounds with N-Methyl Benzothiazolone Hydrazone." 
Archives of Biochemistry and Biophysics. Vol 109. 548-559. September 24, 1964. 
11: Monk, Brian. Senior Thesis. University of Redlands. 2010. 
24 
